The effects of D-23129, a new experimental anticonvulsant drug, on neurotransmitter amino acids in the rat hippocampus in vitro

Epilepsy Research
I M KapetanovicH J Kupferberg

Abstract

D-23129 [N-(2-amino-4-(4-fluorobenzylamino)phenyl)carbamic acid ethyl ester] and D-20443 (dihydrochloride of D-23129) are promising anticonvulsant compounds with a broad spectrum activity in animal models of epilepsy. Their effects on de novo synthesis of excitatory (glutamate and aspartate) and inhibitory (GABA) amino acids were studied in rat hippocampal slices. Like phenytoin, carbamazepine, lamotrigine, losigamone, U54494A, and flupirtine, D-23129 and D-20443 were effective in preventing the effects of a chemoconvulsant, 4-aminopyridine, on de novo synthesis of the three amino acids. However, unlike the other compounds, D-23129 and D-20443 also preferentially increased the concentrations of newly synthesized GABA. Their effect on the neosynthesis of GABA was unique, dose dependent, and not tetrodotoxin sensitive. A total of 15 compounds (including standard, new and candidate anticonvulsants) either had no effect on new GABA or decreased it. Therefore, D-23129 and D-20443 exhibited two different effects on de novo synthesis of neurotransmitter amino acids, both of which could potentially be anticonvulsant in nature.

References

Mar 1, 1992·Epilepsy Research·S Yamaguchi, M A Rogawski
Jan 1, 1986·New Directions for Mental Health Services·W J Rockwell
Sep 1, 1988·Journal of Neurochemistry·M YudkoffD Pleasure
Mar 1, 1964·Journal of Neurochemistry·J E CREMER

❮ Previous
Next ❯

Citations

Mar 7, 2003·European Journal of Pharmacology·Clementina M van Rijn, Elly Willems-van Bree
Jan 5, 2000·European Journal of Pharmacology·R HetkaD Schmitz
Feb 22, 2014·Molecular Pain·Hiroki HayashiTatsumi Matsumoto
Feb 3, 2012·Therapeutics and Clinical Risk Management·Konrad RejdakStanislaw J Czuczwar
Jul 31, 2001·CNS Drugs·S J Czuczwar, P N Patsalos
Jun 21, 2011·Epilepsy Currents·Edward Faught
Dec 31, 2002·Neuropharmacology·Alan D Wickenden
Feb 11, 2015·The American Journal of Drug and Alcohol Abuse·Ewa ZwierzyńskaBogusława Pietrzak
May 29, 2010·Pharmacological Reports : PR·Piotr CzuczwarStanisław J Czuczwar
May 16, 2009·Pharmacological Reports : PR·Jarogniew J Luszczki
Jun 15, 2007·Brain Research Bulletin·R J Fawcett, N N Osborne
Sep 8, 2009·Neuroscience Letters·Karen PadillaKen McCormack
May 4, 2005·CNS Drug Reviews·G Blackburn-MunroR E Blackburn-Munro
Dec 22, 2005·The European Journal of Neuroscience·I Rivera-Arconada, J A Lopez-Garcia
May 16, 2006·Neuropharmacology·Francesca BosciaMaurizio Taglialatela
Jan 5, 2001·Expert Opinion on Investigational Drugs·M C Walker, J W Sander
Nov 4, 2000·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·G J SillsM J Brodie
Sep 27, 2016·PloS One·Monica G RisleyKen Dawson-Scully
Mar 14, 2007·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Wei BuVirginia Borges
Jul 23, 2003·Journal of Psychopharmacology·Heather Ashton, Allan H Young
Sep 20, 2012·The Annals of Pharmacotherapy·Mikiko Yamada, Timothy E Welty
Aug 26, 2015·Journal of Biomolecular Screening·Edward S A Humphries, Caroline Dart
Aug 23, 2000·Molecular Pharmacology·A D WickendenP K Wagoner
May 8, 2019·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Fan ZhangKeWei Wang
May 1, 1997·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·P J McNeillyJ M Strong
Jul 25, 2000·Molecular Pharmacology·M J MainS A Burbidge
May 29, 2021·RSC Medicinal Chemistry·Matteo BorginiPeter Wipf

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.